Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page
- Check7 days agoChange DetectedNo additions or deletions are recorded for this page in the provided changes dataset.SummaryDifference0.1%

- Check14 days agoChange DetectedA new Study Protocol and Statistical Analysis Plan PDF was added to the Study Documents. The data-sharing section was updated to Plan for Individual Participant Data (IPD), reflecting the trial's approach to sharing participant data.SummaryDifference61%

- Check21 days agoChange DetectedThe revision label on the page changed from v3.6.4 to v3.6.5, signaling a new version of the page content or template. This appears to be a routine, minor update that does not modify the study details or user-facing content.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page. This reflects a minor update to the page's metadata and does not affect core content or behavior.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an updated revision tag on the page.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page revision changed from v3.6.0 to v3.6.2. This indicates a minor update to the ClinicalTrials.gov entry, likely related to QC or editorial adjustments rather than changes to the study content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.